The South African on MSN1h
Inside Elon Musk’s ‘glow up’: Plastic surgery, Ozempic and more
The world's richest man, Elon Musk, has reportedly undergone a transformation, including plastic surgery, hair transplants ...
Mass. to play a key role as Novo Nordisk grows beyond Ozempic
Novo Nordisk says Massachusetts plays a key role in its bid to expand beyond its historic focus as a diabetes and obesity ...
biznews.com2h
🔒 FT: Regeneron head says weight-loss drugs could cause ‘more harm than good’
Regeneron, a leading biotech firm, is testing a drug called trevogrumab to preserve lean muscle while using these medications ...
cnbctv183h
Mylan and Novo Nordisk settle US generic Ozempic dispute, Natco Pharma poised for market entry
Mylan and Novo Nordisk have reached a confidential settlement over the generic version of Ozempic, with Natco Pharma holding ...
BioSpace7h
Can CB1 Inhibitors Make a Comeback in Obesity?
After psychological side effects doomed the first generation of cannabinoid receptor 1–targeting drugs for weight loss, Novo ...
Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?
The United States may have reached a turning point in its decades-long battle against obesity. Recent data suggests that 2020 ...
Neuroscience News15h
Study Finds Wegovy Reduces COVID-19 Death Risk by One-Third
A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.